Last reviewed · How we verify
NCT04825886
Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease
trial testing Zotarolimus-Eluting Stent in Coronary Artery Disease in 2,000 participants. Completed in 18 March 2022.
18 March 2021
Quick facts
| Lead sponsor | Chonnam National University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 28 December 2017 |
| Primary completion | 18 March 2021 |
| Estimated completion | 18 March 2022 |
| Sites | 20 locations across South Korea |
Drugs / interventions tested
- Zotarolimus-Eluting Stent
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
- Myocardial Ischemia — all drugs for Myocardial Ischemia →
- Coronary Disease — all drugs for Coronary Disease →
Sponsor
Chonnam National University Hospital
Who can join
19 and older, any sex, with Coronary Artery Disease or Myocardial Ischemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is to evaluation the efficacy and safety of Zotarolimus-Eluting Stent in patients with long coronary artery disease of 25 mm or longer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04825886
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Chonnam National University Hospital trials
Trials by the same sponsor.
- NCT07390461 — Effectiveness of Artificial Intelligence Integrated Mixed Reality-based High-Alert Medications Management Simulation Pro · NA · not yet recruiting
- NCT07482228 — Long-term Clinical Outcomes After Retinal Artery Occlusion · recruiting
- NCT06954714 — Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions · NA · recruiting
- NCT07002164 — Timing of Coronary Angiography in NSTEMI Complicated by Acute HF · NA · recruiting
- NCT06227754 — OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04825886 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chonnam National University Hospital
- Last refreshed: 6 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04825886.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing